| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Dec-06 | | Total Revenue | 106,296 | 66,690 | 42,646 | | Cost of Revenue | 36,417 | 26,429 | 7,129 | | | Gross Profit | 69,879 | 40,261 | 35,517 | | | Operating Expenses | | Research Development | 5,172 | 3,838 | 1,797 | | Selling General and Administrative | 20,320 | 30,026 | 21,124 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 44,387 | 6,397 | 12,596 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,420 | 2,248 | 429 | | Earnings Before Interest And Taxes | 49,807 | 8,645 | 13,025 | | Interest Expense | 250 | 886 | 703 | | Income Before Tax | 49,557 | 7,759 | 12,322 | | Income Tax Expense | 6,085 | 3,539 | 3,751 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 43,472 | 4,220 | 8,308 | | | Non-recurring Events | | Discontinued Operations |
-
| (1,293) |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 43,472 | 2,927 | 8,308 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $43,472 | $2,927 | $8,308 |
|
0.49% Nasdaq 0.00%
Income Statement
